BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 19, 2025
See today's BioWorld
Home
» Biopharmaceutical collaborations: March 2020
To read the full story,
subscribe
or
sign in
.
Biopharmaceutical collaborations: March 2020
April 24, 2020
Biopharma licensings, joint ventures and collaborations, including: Alector, Allogene, Alnylam, Amgen, Astellas, Astrazeneca, Bayer, Biocon, Biofrontera, Biogen, Biontech, Brightinsight, Bristol-Myers Squib, Canndoc, Celator, Codexis, Cytomx, Cytori, Debiopharm, Eli Lilly, Emergent Biosolutions, Epivax, Evotec, Forge, Forma, Fujifilm, Fujitsu, Generex, Hoth, Hypera, Ideaya, I-Mab, Immix, Isoprene, Jiangsu Alphamab, Lonza, Mannkind, Medigene, Medivir, Merck, Merrimack, Mochida, Neurorx, Nicox, Novartis, Novavax, Novotech, Oasmia, Ono, Peptidream, Pfizer, Regeneron, Revive, Sanofi, Sciclone, Shionogi, Simcere, Sorrento, Sutro, Takeda, Trianni, Ultragenyx, Vaxart, Vir, Xencor, Xoma, Zai Lab.
BioWorld
Analysis and data insight